National Wilms Tumor Late Effects Study

Contact: Norman Breslow, Ph.D.

Study Website: http://www.nwtsg.org/External Web Site Policy

Number of Enrolled Cancer Patients/Survivors: 9236 / 7861 alive at last follow-up
Years of Diagnoses of Enrolled Cancer Patients/Survivors: 1969-2002
Approximate Years of Follow-up: Median 14.7 years (IQR 8.4 - 22.8) for those alive at last follow-up
Cancer Sites Represented: Kidney (Wilms Tumor)
Biological Specimens Collected: Blood/Blood Fraction
Normal Tissue
Formalin Fixed Tumor Tissue
Fresh Frozen Tumor Tissue
Urine
(NWTS-5 ONLY - Enrolled 1995-2002, ~2,200 patients)
Treatment Outcome Measures: Physician/Medical Record Reported
  • Symptom Assessment
  • Acute Medical Event
  • Late Medical Event
  • Quality of Life
  • Cancer Recurrence
  • Death
Patient-Reported
  • Symptom Assessment
  • Acute Medical Event
  • Late Medical Event
  • Quality of Life
  • Cancer Recurrence
  • Death
  • Other
Co-morbidities at Study Entry: None
Lifestyle Factors: None
Treatment Data: Surgery
Radiation
Chemotherapy
Treatment Data Assessed By: Chart Abstraction
Is the study open to collaboration? Yes

Return to Top